Adapting the Tumor Board Model for Mental Illness and Cancer
This study examines the feasibility and acceptability of a virtual tumor board for cancer and mental illness for patients with serious mental illness and a new cancer diagnosis. The study also examines the impact on patient care, psychiatric symptoms, and clinician self-efficacy in managing this population.
Checked against the public recordLast updated Aug 3, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Behavioral: Virtual Cancer and Mental Health Tumor Board
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Age ≥ 18 years old 2. Verbal fluency in English 3. SMI (schizophrenia spectrum disorder, bipolar disorder, or major depressive disorder with either prior psychiatric hospitalization, history of suicide attempt/suicidal ideation, Medicaid insurance, and/or comorbid alcohol or opioid use disorder) confirmed by diagnostic evaluation of study psychiatrist 4. New invasive stage I-IV breast, lung, gastrointestinal, genitourinary, or head and neck cancer (highly suspected or confirmed according to documentation by the oncologist or pathology) 5. Oncology consultation at or referral to a MGH Danvers within the past 8 weeks Exclusion Criteria: 1. Have cognitive impairment severe enough to interfere with completing brief study assessments or providing informed consent and does not have a guardian who can provide consent 2. Recurrence of same cancer type 3. Do not have verbal fluency in English
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mass General/North Shore Center for Outpatient CareDanvers, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 3, 2023. Always confirm current availability with the study team.